BRIEF published on 02/12/2026 at 15:56, 7 months 21 days ago China Enhances Rural Industries for Revitalization Agricultural Innovation Rural Revitalization Technological Integration Five-Year Plan Local Agriculture
BRIEF published on 02/12/2026 at 15:56, 7 months 21 days ago La Chine renforce ses industries rurales pour les revitaliser Intégration Technologique Innovation Agricole Revitalisation Rurale Plan Quinquennal Agriculture Locale
BRIEF published on 02/12/2026 at 15:55, 7 months 21 days ago Fuller, Smith & Turner PLC Executes Share Buyback London Stock Exchange Ordinary Shares Share Buyback Fuller, Smith & Turner Deutsche Bank
BRIEF published on 02/12/2026 at 15:55, 7 months 21 days ago Fuller, Smith & Turner PLC procède à un rachat d'actions Rachat D'actions Actions Ordinaires Bourse De Londres Fuller, Smith & Turner Deutsche Bank
BRIEF published on 02/12/2026 at 15:52, 7 months 21 days ago Jaguar Health Secures Licensing Agreement with Future Pak Crofelemer Licensing Agreement Jaguar Health Mytesi Future Pak
BRIEF published on 02/12/2026 at 15:52, 7 months 21 days ago Jaguar Health conclut un accord de licence avec Future Pak Crofelemer Jaguar Health Mytesi Contrat De Licence Future Pak
BRIEF published on 02/12/2026 at 15:05, 7 months 21 days ago Onco-Innovations Adjusts Pricing for Private Placement Private Placement Regulatory Compliance Financial Strategy Onco-Innovations Investment Announcement
BRIEF published on 02/12/2026 at 15:05, 7 months 21 days ago Onco-Innovations ajuste ses tarifs pour les placements privés Placement Privé Stratégie Financière Conformité Réglementaire Onco-Innovations Annonce D'investissement
BRIEF published on 02/12/2026 at 14:35, 7 months 21 days ago NanoViricides Files Orphan Drug Application for NV-387 as MPox Treatment NanoViricides NV-387 Orphan Drug Designation FDA Application MPOX Treatment
BRIEF published on 02/12/2026 at 14:35, 7 months 21 days ago NanoViricides dépose une demande de désignation de médicament orphelin pour le NV-387 dans le traitement de la MPox. NanoViricides NV-387 Désignation De Médicament Orphelin Demande Auprès De La FDA Traitement MPox
Published on 10/05/2026 at 22:30, 4 hours 38 minutes ago EV Nickel Announces Formation of Wholly Owned Subsidiary to Advance Nickel Bioleaching Technology and Canadian Nickel Supply Chain
Published on 10/05/2026 at 14:45, 12 hours 23 minutes ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 12 hours 38 minutes ago Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 12 hours 38 minutes ago Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 13 hours 8 minutes ago Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 22:25, 4 hours 43 minutes ago LumApps Named a Leader in 2026 Gartner® Magic Quadrant™ for Intranet Packaged Solutions
Published on 10/05/2026 at 22:05, 5 hours 3 minutes ago AMPERA SUBMITS COMPREHENSIVE ENGAGEMENT PLAN TO THE U.S. NUCLEAR REGULATORY COMMISSION
Published on 10/05/2026 at 21:10, 5 hours 58 minutes ago Shelly Group Board of Directors considers EUR 70.00 offer price fair and supports Schneider Electric’s voluntary public tender offer
Published on 10/05/2026 at 21:05, 6 hours 3 minutes ago EQS-Adhoc: Shelly Group SE: Board of Directors with positive opinion on the registered voluntary public tender offer by Schneider Electric SE
Published on 10/05/2026 at 20:15, 6 hours 53 minutes ago EQS-Adhoc: United Internet AG participates in capital increase against contributions in kind at 1&1 AG
Published on 10/05/2026 at 22:12, 4 hours 56 minutes ago AXA - Elimination of the dilutive impact of Shareplan 2026
Published on 10/05/2026 at 22:12, 4 hours 56 minutes ago AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
Published on 10/05/2026 at 18:13, 8 hours 55 minutes ago Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 8 hours 55 minutes ago Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 9 hours 8 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
